Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pain × Doxycycline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pleural Effusion, Malignant 4 Breast Neoplasms 4 Immunoglobulin Light-chain Amyloidosis 3 Carcinoma, Non-Small-Cell Lung 3 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Exanthema 2 Colorectal Neoplasms 2 Amyloidosis 2 Waldenstrom Macroglobulinemia 1 Urologic Neoplasms 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Tissue Adhesions 1 Skin Toxicity 1 Sezary Syndrome 1 Polyps 1 Pain 1 Ovarian Neoplasms 1 Neurofibromatosis 2 1 Neoplasms, Second Primary 1 Neoplasms 1 Myoma 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1

Interventions

Fentanyl 21 Analgesia 18 Acupuncture Therapy 17 Morphine 16 Zoledronic Acid 13 Oxycodone 12 Acetaminophen 12 Lidocaine 11 Ketamine 11 Therapeutics 10 Radiotherapy 10 Methadone 10 Ibandronic Acid 10 Hydromorphone 10 Bupivacaine 8 nabiximols 7 Surveys and Questionnaires 7 Ropivacaine 7 Early Intervention, Educational 6 Water 5 Tapentadol 5 Psychiatric Rehabilitation 5 Pregabalin 5 Methods 5 Docetaxel 5 Cryotherapy 5 Cryosurgery 5 Analgesics, Opioid 5 Yoga 4 Therapeutic Touch 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01847976 2019-09-06

OTT12-05

Ottawa Hospital Research Institute

Phase 2 Completed

Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡